Current Valuation
N/A
As of June 1, 2024
Total Funding Raised
$122.6M
Last Round
Later Stage VC

$760.0K

Last Funding
Jun 2024

Funding date

Capital Efficiency
N/A

Valuation / Funding

Funding History & Valuation Timeline
Complete history of all funding rounds and valuation milestones

No funding history available

Funding data has not been imported for this company yet

Valuation Analysis

Current Valuation Metrics

Unibio is currently valued at N/A as of June 1, 2024. The company has raised a total of $122.6M in funding.

Investment Perspective

Unibio's valuation reflects investor confidence in the company's market position, growth potential, and ability to execute on its business model. Private market valuations are determined by primary funding rounds and secondary market transactions, which take into account financial performance, market conditions, and growth prospects.

Track Unibio Valuation Updates

Get notified when Unibio raises new funding or valuation changes

What is Unibio Worth in 2025?

As of 2025, Unibio is valued at N/A, based on the company's Later Stage VC funding round in June 1, 2024. This valuation positions Unibio as one of the leading private companies in the sector.

Unibio Valuation History

Unibio's funding history demonstrates steady growth and investor confidence.

How Unibio Valuation is Determined

Private company valuations like Unibio's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including:

  • Revenue growth and financial performance
  • Market opportunity and total addressable market (TAM)
  • Competitive positioning and market share
  • Management team strength and execution capability
  • Technology and intellectual property
  • Industry trends and investor sentiment

Unibio Valuation FAQs

Is Unibio profitable?

Unibio has not publicly disclosed its profitability status. Many high-growth private companies prioritize market expansion and user growth over profitability in their early stages.

How does Unibio's valuation compare to competitors?

Unibio is valued at N/A, positioning it as a major player in the space. Secondary market pricing and private market transactions provide ongoing validation of this valuation.

When will Unibio IPO?

Unibio has not announced plans for an initial public offering. Until an IPO, investors can access Unibio shares through secondary market platforms.